Ignite Creation Date:
2024-05-06 @ 2:27 AM
Last Modification Date:
2024-10-26 @ 11:18 AM
Study NCT ID:
NCT02040870
Status:
COMPLETED
Last Update Posted:
2019-02-20
First Post:
2014-01-17
Brief Title:
LDK378 in Adult Chinese Patients With ALK-rearranged ALK-positive Advanced Non-small Cell Lung Cancer NSCLC Previously Treated With Crizotinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-17
First Submit QC Date:
January 17 2014
Study First Post Date:
2014-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-01-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-30
Last Update Post Date:
2019-02-20
Last Update Post Date Type:
ACTUAL